Guardant Health
GH
#3260
Rank
โ‚น303.57 B
Marketcap
โ‚น2,457
Share price
-3.64%
Change (1 day)
32.20%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚น134.94 Billion

According to Guardant Health 's latest financial reports the company's total liabilities are โ‚น134.94 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Guardant Health - Total liabilities on balance sheet (from 2017 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚น135.50 B5.66%
2022-12-31โ‚น128.24 B10.49%
2021-12-31โ‚น116.07 B73.24%
2020-12-31โ‚น67.00 B720.32%
2019-12-31โ‚น8.16 B87.05%
2018-12-31โ‚น4.36 B99.2%
2017-12-31โ‚น2.19 B-12.5%
2016-12-31โ‚น2.50 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น57.43 B-57.44%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น115.46 B-14.44%๐Ÿ‡บ๐Ÿ‡ธ USA